Pharmacological activity of (−)‐discretamine, a novel vascular α‐adrenoceptor and 5‐hydroxytryptamine receptor antagonist, isolated from Fissistigma glaucescens

Authors:

Abstract
The pharmacological activity of (−)‐discretamine, isolated from Fissistigma glaucescens, was determined in rat isolated thoracic aorta, cardiac tissues and ventricular myocytes and guinea‐pig isolated trachea. (−)‐Discretamine was found to be an α1‐adrenoceptor blocking agent in rat thoracic aorta as revealed by its competitive antagonism of noradrenaline (pA2 = 7.20 ± 0.10)‐ or phenylephrine (pA2 = 7.60 ± 0.09)‐induced vasoconstriction. It was as potent as phentolamine (pA2 = 7.51 ± 0.10), but was more potent than yohimbine (pA2 = 6.18 ± 0.06). Removal of endothelium significantly increased the antagonistic potency of (−)‐discretamine on noradrenaline (pA2 = 7.52 ± 0.09)‐ or phenylephrine (pA2 = 7.90 ± 0.09)‐induced vasoconstriction. (−)‐Discretamine was also an α2‐adrenoceptor blocking agent (pA2 = 6.30 ± 0.15) and a 5‐hydroxytryptamine antagonist (pA2 = 6.87 ± 0.06), both in rat aorta denuded of endothelium. (−)‐Discretamine protected α‐adrenoceptors from alkylation by the irreversible blocking agent, phenoxybenzamine. [3H]‐inositol monophosphate formation caused by noradrenaline (3 μm) in rat thoracic aorta was suppressed by (−)‐discretamine (10 and 30 μm) and prazosin (3 μm). A high concentration of (−)‐discretamine (30 μm) did not affect the contraction induced by the thromboxane receptor agonist U‐46619, prostaglandin F2α (PGF2α), angiotensin II, high K+ or endothelin in rat aorta denuded of endothelium. Neither cyclic AMP nor cyclic GMP content of rat thoracic aorta was changed by (−)‐discretamine. Contraction of guinea‐pig trachea caused by histamine, leukotriene C4 or carbachol was not affected by (−)‐discretamine (30 μm). (−)‐Discretamine also did not block β1 or β2‐adrenoceptor‐mediated responses induced by isoprenaline in rat right atria and guinea‐pig trachea. A voltage clamp study in rat ventricular single myocytes revealed that sodium inward current, slow inward Ca2+ current or transient (Ito) and steady state (I800) outward current was not affected by (−)‐discretamine (30 μm). It is concluded that (−)‐discretamine is a selective α‐adrenoceptor and 5‐HT receptor antagonist in vascular smooth muscle.

This publication has 22 references indexed in Scilit: